SAGE THERAPEUTICS INC shareholders Q3 2023

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Parallax Volatility Advisers, L.P. 13,500$277,8300.00%
WELLS FARGO & COMPANY/MN 88,109$1,813,2830.00%
CAPITAL FUND MANAGEMENT S.A. 10,800$222,2640.00%
AMALGAMATED BANK 7,834$1610.00%
DekaBank Deutsche Girozentrale 22,220$4610.00%
Ensign Peak Advisors, Inc 31,010$638,1860.00%
ProShare Advisors LLC 10,782$221,8940.00%
NEW YORK STATE COMMON RETIREMENT FUND 22,688$4670.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 9,289$191,1680.00%
BANK OF AMERICA CORP /DE/ 496,593$10,219,8840.00%
GOLDMAN SACHS GROUP INC 313,106$6,443,7210.00%
Walleye Trading LLC 16,004$329,3620.00%
Baker Avenue Asset Management, LP 33$6790.00%
WOLVERINE TRADING, LLC 13,700$281,9460.00%
Walleye Trading LLC 3,700$76,1460.00%
Walleye Trading LLC 1,000$20,5800.00%
North Star Investment Management Corp. 194$3,9930.00%
NISA INVESTMENT ADVISORS, LLC 550$11,3190.00%
Sandy Spring Bank 100$2,0580.00%
Daiwa Securities Group Inc. 239$50.00%
External links

This page lists SAGE THERAPEUTICS INC's shareholders in Q3 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.